<DOC>
	<DOCNO>NCT00509080</DOCNO>
	<brief_summary>The purpose study determine use BNP/NT-proBNP level detection early leave ventricular dysfunction damage may improve time cardiac surgery therefore long-term management asymptomatic patient severe mitral regurgitation .</brief_summary>
	<brief_title>Prognosis Asymptomatic Mitral Regurgitation ( PAMIR ) Study</brief_title>
	<detailed_description>Background : One difficult issue care asymptomatic patient severe valvular heart disease , particularly mitral regurgitation , time surgical intervention . Unlike stenotic lesion , regurgitant lesion often progress insidiously , cause leave ventricular damage symptom develop . Current criterion surgical intervention include leave ventricular dimension leave ventricular ejection fraction . The clinical problem morphologic criterion fulfil , prognosis already worsen , even surgery perform promptly . In addition , onset symptom may difficult detect physical inactivity under-reporting . In patient , may unclear whether symptom relate valvular heart disease condition . Natriuretic peptide include B-type natriuretic peptide ( BNP ) NT-proBNP may sensitive marker leave ventricular damage morphologic study echocardiography . The use BNP NT-proBNP level may help time surgical intervention irreversible leave ventricular damage occur . Previous experience BNP NT-proBNP test patient valvular heart disease limit , albeit promise . Aim : To test hypothesis : - Elevated BNP/NT-proBNP level reflect early left right ventricular dysfunction indicate imminent congestive heart failure cardiac decompensation , call surgical intervention . - The BNP/NT-proBNP level sensitive marker ventricular damage ventricular dimension leave ventricular ejection fraction . - Low BNP/NT-proBNP level indicate low event rate medical therapy may therefore reassure `` wait see strategy '' . Patients method : The prospective cohort study design enrol 200 patient severe mitral regurgitation follow 4-year period . Natriuretic peptide include BNP NT-proBNP measure addition detailed clinical , electrocardiographic , echocardiographic assessment prospectively repetitively patient severe mitral regurgitation routine consultation 6 month interval . Our primary analysis ( longitudinal study ) focus prognosis asymptomatic patient . In addition , sub-study also include symptomatic patient severe mitral regurgitation whether schedule undergo valvular surgery ( cross sectional study ) order obtain reliable data regard BNP/NT-proBNP level patient formal indication valvular surgery . The treat physician remain blind BNP/NT-proBNP value . In cohort study , try identify BNP/NT-proBNP cut-off value predict major adverse cardiac event include cardiac death , congestive heart failure , myocardial infarction , persistent leave ventricular systolic dysfunction 6 month valvular surgery . Clinical Significance : The use BNP/NT-proBNP level detection early leave ventricular dysfunction damage may improve time cardiac surgery therefore long-term management asymptomatic patient severe mitral regurgitation .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Patients severe isolated mitral regurgitation due valvular disease Missing write patient consent Active infective endocarditis Relative mitral regurgitation due leave ventricular disease Other moderate severe dysfunctional valve Previous cardiac surgery Pregnancy Sepsis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>mitral regurgitation</keyword>
	<keyword>BNP</keyword>
	<keyword>NT-proBNP</keyword>
	<keyword>natriuretic peptide</keyword>
	<keyword>valvular heart disease</keyword>
</DOC>